ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Endocrine Cancer
ENDOCRINE CANCER ADVISOR
FEATURED CONTENT
-
-
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP. -
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future. -
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity. -
American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
ENDOCRINE CANCER NEWS
Vandetanib and Cabozantinib Deemed Effective in Real-World Study of Medullary Thyroid Cancer
Local Resection Is ‘Sufficient’ for Parathyroid Carcinoma
Lenvatinib Produces ‘Strong’ Responses in Resistant Gastroenteropancreatic Neuroendocrine Tumors
Lenvatinib Monotherapy Produces Low Response Rate in Anaplastic Thyroid Cancer
Cabozantinib Improved PFS, May Be New Standard for Radioiodine-Refractory Thyroid Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Endocrine Cancer
Loading... 
Loading...